Stock Earnings

Question 1

Protagonist Therapeutics Inc의 주요 재무제표는 무엇인가요?

Accepted Answer

최신 재무제표(Form-10K)에 따르면, Protagonist Therapeutics Inc의 총 자산은 $744이며, 순profit입니다.

Question 2

PTGX의 주요 재무 비율은 무엇인가요?

Accepted Answer

Protagonist Therapeutics Inc의 유동비율은 10.78이고, 순이익률은 63.36, 주당 매출은 $6.66입니다.

Question 3

Protagonist Therapeutics Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?

Accepted Answer

Protagonist Therapeutics Inc largest revenue segment is Peptide Therapeutics, at a revenue of 434,433,000 in the most earnings release.For geography, United States is the primary market for Protagonist Therapeutics Inc, at a revenue of 434,433,000.

Question 4

Protagonist Therapeutics Inc은 수익성이 있나요?

Accepted Answer

yes, 최신 재무제표에 따르면 Protagonist Therapeutics Inc의 순profit은 $275입니다.

Question 5

Protagonist Therapeutics Inc에 부채가 있나요?

Accepted Answer

yes, Protagonist Therapeutics Inc의 부채는 69입니다.

Question 6

Protagonist Therapeutics Inc의 발행 주식은 몇 주인가요?

Accepted Answer

Protagonist Therapeutics Inc의 총 발행 주식은 61.03주입니다.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	209	434	60	26	27	28
Revenue Growth (YoY)	-35%	623%	131%	-4%	-4%	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	42	43	33	31	27	18
Research & Development	147	138	120	126	126	74
Operating Expenses	190	181	153	157	153	93
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	48	279	-78	-127	-125	-64
Income Tax Expense	2	4	--	0	0	1
Net Income	45	275	-78	-127	-125	-66
Net Income Growth	-74%	-453%	-39%	2%	89%	-14%
Shares Outstanding (Diluted)	63.77	65.07	56.76	49.04	46.32	34.4
Shares Change (YoY)	3%	15%	16%	6%	35%	33%
EPS (Diluted)	0.71	4.22	-1.39	-2.6	-2.71	-1.92
EPS Growth	-74%	-404%	-47%	-4%	41%	-36%
Free Cash Flow	63	182	-70	-108	-108	-72
Free Cash Flow Per Share	0.98	2.79	-1.23	-2.2	-2.33	-2.09
Gross Margin	--	--	--	--	--	--
Operating Margin	9.09%	58.06%	-155%	-503.84%	-462.96%	-228.57%
Profit Margin	21.53%	63.36%	-130%	-488.46%	-462.96%	-235.71%
Free Cash Flow Margin	30.14%	41.93%	-116.66%	-415.38%	-400%	-257.14%
EBITDA	20	254	-90	-130	-125	-64
EBITDA Margin	9.56%	58.52%	-150%	-500%	-462.96%	-228.57%
D&A For EBITDA	1	2	3	1	0	0
EBIT	19	252	-93	-131	-125	-64
EBIT Margin	9.09%	58.06%	-155%	-503.84%	-462.96%	-228.57%
Effective Tax Rate	4.16%	1.43%	--	0%	0%	-1.56%

Protagonist Therapeutics Inc (PTGX) Price

PTGX Stock Price Chart

PTGX Income

Follow-Up Questions